Guardant Health GH Ratios (2017-2026)

NASDAQ GH
$168.40 -2.51 (-1.47%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Guardant Health Quarterly Ratios

Periods 36 quarters
Latest Jun 2026

Guardant Health reported a gross margin of 65.39% and a net margin of -35.87% for the quarter ended Jun 2026. These financial ratios cover 36 quarters of results from Sep 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
61.25%59.14%61.10%61.55%63.28%65.01%64.71%64.63%65.22%65.39%
EBT Margin
-113.35%-66.88%-128.26%-209.80%-137.88%-109.80%-103.56%-52.70%-59.86%-120.98%-68.00%-57.83%-56.26%-54.65%-46.63%-43.03%-34.91%-46.30%-37.03%-35.81%
EBIT Margin
-113.20%-90.84%-128.34%-119.40%-123.16%-115.15%-104.15%-87.22%-79.38%-127.38%-59.16%-56.77%-61.28%-62.42%-54.57%-45.85%-37.33%-42.95%-40.23%-38.55%
EBITDA Margin
-113.20%-90.84%-128.34%-119.40%-123.16%-115.15%-104.15%-87.22%-79.38%-127.38%-59.16%-56.77%-61.28%-62.42%-54.57%-45.85%-37.33%-42.95%-40.23%-38.55%
Operating Margin
-113.20%-90.84%-128.34%-119.40%-123.16%-115.15%-104.15%-87.22%-79.38%-127.38%-59.16%-56.77%-61.28%-62.42%-54.57%-45.85%-37.33%-42.95%-40.23%-38.55%
Net Margin
-113.45%-84.09%-128.23%-210.21%-137.98%-110.28%-103.74%-53.06%-60.20%-120.63%-68.24%-57.91%-56.28%-55.00%-46.77%-43.04%-34.96%-45.68%-37.15%-35.87%
FCF Margin
-79.44%-93.99%-53.40%-123.66%-85.08%-79.40%-64.06%-72.94%-56.05%-53.40%-22.09%-55.90%-28.86%-41.32%-33.00%-28.41%-17.26%-19.28%-23.60%-20.76%
Efficiency
Inventory AverageInventory Avg.
25.62M27.71M33.64M48.25M61.47M57.32M49.04M53.50M68.78M69.49M62.47M64.99M69.64M71.69M74.17M80.66M87.28M88.18M84.86M94.66M
Assets AverageAssets Avg.
2,258.71M2,215.02M2,167.05M1,991.67M1,777.76M1,655.88M1,560.81M1,675.82M1,818.62M1,791.83M1,745.51M1,656.97M1,574.03M1,512.17M1,414.92M1,338.11M1,304.39M1,645.22M1,964.47M1,913.79M
Asset Utilization RatioAsset Util.
0.150.170.180.200.240.270.310.300.290.310.350.390.440.490.550.620.690.600.550.62
Leverage & Solvency
Interest Coverage RatioInterest Cover
-166.60-152.73-191.52-202.05-224.53-226.89-208.16-185.45-176.31-306.22-154.55-156.00-181.62-195.29-140.38-108.25-104.97-102.38-90.09-95.93
Times Interest Earned
-166.60-152.73-191.52-202.05-224.53-226.89-208.16-185.45-176.31-306.22-154.55-156.00-181.62-195.29-140.38-108.25-104.97-102.38-90.09-95.93
Valuation
Enterprise Value
-1426.57M-932.75M-962.27M-853.69M-958.04M-1011.23M-937.09M-1224.95M-1154.85M-1168.63M-1029.03M-933.69M-895.72M-839.98M-698.57M-629.14M-580.01M-1201.60M-1102.76M-1053.47M
Return Ratios
Return on SalesROS
-0.01%-0.01%-0.01%-0.02%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Capital EmployedROCE
-18.73%-20.34%-22.00%-25.17%-30.98%-37.22%-40.92%-36.91%-32.25%-35.61%-34.77%-35.14%-37.42%-34.48%-38.26%-41.90%-41.44%-32.57%-26.76%-29.86%
Return on AssetsROA
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%